250 related articles for article (PubMed ID: 32633635)
1. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.
Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635
[TBL] [Abstract][Full Text] [Related]
2. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
3. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
[TBL] [Abstract][Full Text] [Related]
4. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.
Mets E; Van der Meulen J; Van Peer G; Boice M; Mestdagh P; Van de Walle I; Lammens T; Goossens S; De Moerloose B; Benoit Y; Van Roy N; Clappier E; Poppe B; Vandesompele J; Wendel HG; Taghon T; Rondou P; Soulier J; Van Vlierberghe P; Speleman F
Leukemia; 2015 Apr; 29(4):798-806. PubMed ID: 25231743
[TBL] [Abstract][Full Text] [Related]
6. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein PUM2 promotes T-cell acute lymphoblastic leukemia via competitively binding to RBM5 3'UTR with miR-28-5p.
Bai T; Liu N
Eur J Haematol; 2023 May; 110(5):498-509. PubMed ID: 36536516
[TBL] [Abstract][Full Text] [Related]
8. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Ngoc PCT; Tan SH; Tan TK; Chan MM; Li Z; Yeoh AEJ; Tenen DG; Sanda T
Leukemia; 2018 Oct; 32(10):2138-2151. PubMed ID: 29654272
[TBL] [Abstract][Full Text] [Related]
10. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
11. miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
Jiang J; Liu Y; Zhao Y; Tian F; Wang G
Technol Cancer Res Treat; 2019; 18():1533033819852990. PubMed ID: 31138034
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
13. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
14. The enhancer RNA
Tan SH; Leong WZ; Ngoc PCT; Tan TK; Bertulfo FC; Lim MC; An O; Li Z; Yeoh AEJ; Fullwood MJ; Tenen DG; Sanda T
Blood; 2019 Jul; 134(3):239-251. PubMed ID: 31076442
[TBL] [Abstract][Full Text] [Related]
15. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
[TBL] [Abstract][Full Text] [Related]
16. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).
Shaw TI; Dong L; Tian L; Qian C; Liu Y; Ju B; High A; Kavdia K; Pagala VR; Shaner B; Pei D; Easton J; Janke LJ; Porter SN; Ma X; Cheng C; Pruett-Miller SM; Choi J; Yu J; Peng J; Gu W; Look AT; Downing JR; Zhang J
Sci Rep; 2021 Mar; 11(1):5154. PubMed ID: 33664368
[TBL] [Abstract][Full Text] [Related]
17. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-mediated silencing of microRNA-204 enhances T cell acute lymphoblastic leukemia by up-regulating MMP-2 and MMP-9 via NF-κB.
Lin C; Chen D; Xiao T; Lin D; Lin D; Lin L; Zhu H; Xu J; Huang W; Yang T
J Cell Mol Med; 2021 Mar; 25(5):2365-2376. PubMed ID: 33566449
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.
Mets E; Van Peer G; Van der Meulen J; Boice M; Taghon T; Goossens S; Mestdagh P; Benoit Y; De Moerloose B; Van Roy N; Poppe B; Vandesompele J; Wendel HG; Van Vlierberghe P; Speleman F; Rondou P
Haematologica; 2014 Aug; 99(8):1326-33. PubMed ID: 24895337
[TBL] [Abstract][Full Text] [Related]
20. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
